Trimetal-arene clusters with anticancer activity

The invention relates to new medicaments, pharmaceutical compns. and methods of treatment of cancer. The invention discloses trimetallic clusters for use as a medicament, in particular in the treatment of cancer including metastasis. Preferably, the compds. are provided in the form of pharmaceutically acceptable salts. Preferred compd. include trinuclear ruthenium-arene clusters.


Year:
2009
Other identifiers:
EPO Family ID: 38724544
TTO: 6.0774
Laboratories:




 Record created 2009-06-15, last modified 2018-01-28


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)